Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2-
Clinical trial NCT05140655 · UNKNOWN
Trial details
- NCT number
- NCT05140655
- Sponsor
- Dr. Reddy's Laboratories SAS
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-04-19
- Primary completion
- 2022-04-19
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.